Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2010
08/17/2010US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH)
08/17/2010US7776361 NELL-1 enhanced bone mineralization
08/17/2010US7776322 infectious adenovirus viral vector particle comprising an adenovirus capsid Fiber protein; use of these viral vector particles as a therapeutic, prophylactic or diagnostic means in humans and primates as well as other vertebrates like cattle, pigs, birds, fish, or rodents
08/17/2010US7776321 A nucleic acid construct encoding the antigenic determinant of a mutable pathogen; an isolated cell containing the construct; genetic engineering; vaccination; immunotherapy
08/17/2010US7776320 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
08/17/2010CA2389036C Antisense modulation of integrin-linked kinase expression
08/17/2010CA2365907C Enhancement of the immune response for vaccine and gene therapy applications
08/17/2010CA2364314C Non-squamous epithelium-specific transcription
08/17/2010CA2318571C Methods of controlling cell differentiation and growth using a fusion protein and a drug
08/17/2010CA2284665C Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
08/17/2010CA2271955C Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
08/17/2010CA2200695C Cationic transport reagents
08/17/2010CA2169260C Gene therapy for solid tumors, papillomas and warts
08/12/2010WO2010090876A2 Satiation peptide administration
08/12/2010WO2010090452A2 Small interference rna complex with increased intracellular transmission capacity
08/12/2010WO2010089442A1 Method for treating neurodegenerative diseases
08/12/2010WO2010088927A1 Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
08/12/2010WO2010050802A3 Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53.
08/12/2010WO2010045199A3 Method of modulating ship activity
08/12/2010WO2010042868A3 Methods for treating obesity
08/12/2010US20100204458 Process for the Production of Immunogenic Compositions
08/12/2010US20100204453 Antibodies to tumor associated proteins
08/12/2010US20100204448 Method and carrier complexes for delivering molecules to cells
08/12/2010US20100204308 Cell proliferation inhibitory proteins and polynucleotides, antisense polynucleotides to the polynucleotides, cell proliferation inhibitors using the foregoing, cancer diagnostic agents, cancer therapeutic agents and compositions for gene therapy
08/12/2010US20100204307 Compositions And Methods For Inhibiting Expression Of The HAMP Gene
08/12/2010US20100204301 Reducible polymers for nonviral gene delivery
08/12/2010US20100204297 Influenza therapeutic
08/12/2010US20100204253 Ribosome Structure and Protein Synthesis Inhibitors
08/12/2010US20100204125 Genetic alterations associated with cancer
08/12/2010US20100204091 SIVA Ubiquitination and/or Degradation-Related Activity and Modulators Thereof
08/12/2010US20100204087 Tribonectins
08/12/2010US20100204051 Hereditary Hemochromatosis Gene
08/12/2010US20100203628 Novel modified galectin 9 proteins and use thereof
08/12/2010US20100203080 Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof
08/12/2010US20100203074 Compositions and methods for treating intracellular diseases
08/12/2010US20100203072 Circovirus sequences associated with piglet weight loss disease (pwd)
08/12/2010US20100203060 Inhibitors for growth hormone and related hormones, and methods of use thereof
08/12/2010US20100203036 Targets for tumor growth inhibition
08/12/2010US20100203029 Lysyl oxidase-like 1 (loxl1) and elastogenesis
08/12/2010US20100203024 Sickled Erythrocytes, Nucleated Precursors & Erythroleukemia Cells for Targeted Delivery of Oncolytic Viruses, Anti-tumor Proteins, Plasmids, Toxins, Hemolysins & Chemotherapy
08/12/2010US20100202977 Modulation of Stat 6 Expression for the Treatment of Airway Hyperresponsiveness
08/12/2010DE102009007929A1 Use of L-ribozymes (which are capable of splitting L-RNA in a region of a target sequence) for preparing composition to treat undesired physiological secondary reactions due to administration of a therapeutic molecule containing L-RNA
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216407A2 Therapeutic Compositions
08/11/2010EP2216400A1 Method for manufacturing an active component of a medicine or diagnosis agent in MDCJ cell suspension culture
08/11/2010EP2216043A1 Use of inductor agents gse24.2 for producing pharmaceutical compositions for treating illnesses relating to cellular senescence
08/11/2010EP2216029A2 Oligonucleotides for treatment of prostate and other cancers
08/11/2010EP2215218A1 Induction of pluripotent stem cells into mesodermal lineages
08/11/2010EP2214717A1 Means and methods for eliciting an immune response
08/11/2010EP2214698A2 Use of compounds activating sirt-3 for mimicking exercise
08/11/2010EP1633327B1 Method for improving stability and shelf-life of liposome complexes
08/11/2010EP1569696B1 Methods and immune modulatory nucleic acid compositions for preventing and treating disease
08/11/2010EP0672160B1 Activating expression of an amplifying endogenous gene by homologous recombination
08/11/2010CN1952160B Recombinant of intelligent adenovirus vector and khp53 gene and application thereof
08/11/2010CN101802186A Plasmid containing a sequence encoding a disintegrin domain of metargidin (RDD)
08/11/2010CN101801419A MiR-34 regulated genes and pathways as targets for therapeutic intervention
08/11/2010CN101801418A Compositions comprising human EGFR-SIrna and methods of use
08/11/2010CN101801353A Adhering troches with topically active ingredients for treatment of throat, esophagus, and stomach
08/11/2010CN101798600A Application of SERPINE2 gene
08/11/2010CN101798599A Purpose of hsa-miR-150
08/11/2010CN101798349A Anti-uPAR humanized antibody and coding gene thereof
08/11/2010CN101798348A Anti-uPAR humanized antibody and application thereof
08/11/2010CN101797390A Application of gene rabl3 antagonist and medicament containing same
08/11/2010CN101797387A Magnetic targeting carrier capable of carrying gene and drug, preparation method and application thereof
08/11/2010CN101797229A Immune liposome based on Isthmin gene as well as preparation method and application thereof
08/11/2010CN101361984B Use of Dpys 12 gene in preparing medicine for inhibiting or promoting early neurogenesis
08/10/2010US7772205 Recombinant plasmid vector; nucleic acid sequence encoding a BMP-7 polypeptide operatively linked to a promoter; IGF-1 signal sequence, tPA signal sequence; signal peptide encoded by a nucleotide sequence; hemodynamic-based plasmid DNA gene delivery; delivery of naked plasmid; occlusion balloon catheter
08/10/2010US7772203 Useful in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing; enhancing silencing of a target mRNA
08/10/2010US7771979 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
08/10/2010US7771931 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/10/2010US7771930 Identifying mutation in nucleotide sequences coding immunoglobulin domain carrying polypeptide for use in diagnosis and prognosis of cell proliferative disorders
08/10/2010US7771715 Recombinant vector expressing multiple costimulatory molecules and uses thereof
08/10/2010US7771714 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
08/10/2010US7771711 Sphingolipids' polyalkylamines conjugates
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2391507C Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
08/10/2010CA2361238C Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/10/2010CA2319309C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
08/10/2010CA2267095C Nucleotide and protein sequence of mammastatin and methods of use
08/10/2010CA2180032C Gene expression control
08/10/2010CA2165969C Vertebrate apoptosis gene: compositions and methods
08/05/2010WO2010088565A1 Nucleic acid delivery using modified chitosans
08/05/2010WO2010088560A1 Methods for distributing high levels of therapeutic agent throughout the cortex to treat neurological disorders
08/05/2010WO2010088457A2 Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase i inhibitors
08/05/2010WO2010088276A2 Polynucleotide aptamer-based cross -linked materials and uses thereof
08/05/2010WO2010087497A1 Pharmaceutical composition, and pharmaceutical preparation for treating tumors
08/05/2010WO2010087131A1 Hiv replication inhibitor, and use thereof
08/05/2010WO2010086406A1 Non-viral transfection agent
08/05/2010WO2010086189A2 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
08/05/2010WO2010085984A1 Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
08/05/2010WO2010066046A8 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
08/05/2010WO2010062322A3 Modulation of the immune response
08/05/2010WO2010028093A3 Use of a truncated elf-5a1 polynucleotide to induce apoptosis in cancer cells
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199366 Gene therapy using transposon-based vectors
08/05/2010US20100197015 Human liver progenitors
08/05/2010US20100196998 System and method for electroporating a sample
08/05/2010US20100196957 Cloning and characterization of 5' flanking regions of a human aggrecanase-1 gene
08/05/2010US20100196916 Drug Screening using Islet Cells and Islet Cell Progenitors from Human Embryonic Stem Cells
08/05/2010US20100196458 Modified cytokines for use in cancer therapy
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 870